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S'-Deamino-S'-morpholino-lS-deoxo-lO-hydroxycarminomycin (MX2) is a new morpholino
anthracycline agent derived from 1 3-deoxo-10-hydroxycarminomycin (R20X2) by replacement of the 3'-ammo group of the daunosamine residue with a morpholino groups. MX2has several unique characteristics which make it attractive for clinical application. MX2is equally cytotoxic against doxorubicin-sensitive and -resistent P388 leukemia cells2 '3) , is active against intracerebrally-inoculated LI210 leukemia and is active by oral administration^. MX2 is less cytotoxic than its parent drug, R20X2 as judged by in vitro cytotoxicity and in vivo assays1»2) in contrast to morpholinoadriamycin which is 2 to 3 times more cytotoxic than doxorubicin4). In order to obtain information on the factors which reduce the cytotoxicity of MX2, we compared MX2with R20X2 with respect to their biological activities which were regarded as critical factors for cytotoxicity. The results suggest that a) MX2and R20X2 bind irreversibly to DNA in P388 cells, b) this binding occurs non enzymatically, and c) the low cyto- toxicity of MX2is due to its low binding activity to DNA.
Materials and Methods
MX2and R20X2 were prepared at our laboratory. Proteinase K and calf thymus DNA(Type I) were from Sigma. For P388 cell incubation experiments, RPMI-1640 medium supplemented with 10% fetal calf serum, lOO u/ml benzylpenicillin, 0.1 mg/ml streptomycin and 0.05 him 2-mercaptoethanol was used. P388 leukemia was maintained in female DBA/2mice. P388 cells were harvested from the peritoneal cavity of tumor-bearing mice and maintained in mediumat 37°C in a humidified atmosphere of 5 % CO2.
Cytotoxicity Assay P388 cells (1 x 104 cells/ml) were treated with graded concentration of MX2and R20X2 at 37°C for 1 hour in medium. The drug was then removedby centrifugation and washing. The cells were resuspended in fresh medium, incubated at 37°C for 3 days and counted with a Model ZBI Coulter counter.
Intracellular and Intranuclear Concentration
P388 cells (1 x 106 cells/ml) were incubated with 1^m MX2or R20X2 at 37°C for 1 hour in medium. The drug was removed by centrifugation and washing with Hanks' balanced salt solution (HBSS). The cells were then resuspended in 0.3 n HC1in 50% ethanol at 37°C for 30 minutes and centrifuged. The fluorescence of the supernatant was measured at an excitation of 470 nmand emission of 550 nm. Drug content was calculated by comparison with standard solutions of the drugs.
The washed cells thus obtained were solubilized with HBSScontaining 0.1 % Nonidet P-40 at 0°C for 5 minutes and centrifuged. The resulting nuclear pellets were extracted with 0.3 n HC1in 50% ethanol and fluorescence was measured.
DNA-intercalati on Quenching of the fluorescence of MX2and R20X2was measured in reaction mixtures each containing 5 fiM anthracyclines and varying amounts of calf thymus DNAin a manner analogous to that of previous studies5>6). The reagents were dissolved in 50 mMNaCl, 1 him EDTAand 50 him sodium phosphate buffer (pH 7.4) and were mixed at 25°C. After 1 hour, fluorescence was measured at excitation of 470 nmand emission of 550 nm. The concentration of DNAwas expressed as nucleotide concentration. The binding data were analyzed by the Scatchard method.
DNA-binding in P388 Cells
P388 cells (2 x 107 cells/5 ml) were incubated with 100^m anthracycline at 37°C in medium. The cells were then chilled on ice and centrifuged. The resulting cell pellets were washed with 5 ml HBSS, solubilized with 3 ml HBSS containing 0.1 % Nonidet P-40 for 5 minutes at 0°C and centrifuged. The resulting nuclear pellets were suspended in 2 ml of 1 % sodium dodecylsulfate (SDS), 50 him EDTA, 100mMTris-HCl (pH 8.5) and digested with 1 mg/ml proteinase K at 37°C for 2 to 5 hours. This was followed by extraction three times with 2 ml of water-saturated phenol -chloroform (1 : 1). The aqueous fractions were dialyzed against 0.9% NaCl for 18 hours at 4°C and added to 8 ml of 2-propanol. The precipitated DNA-drug complexes were hydrolyzed with 2 ml of 5 %HC1O4for 20 minutes at 70°C and centrifuged. The fluorescence of the supernatants was measured at excitation of 470 nm and emission of 550 nm. An aliquot of the supernatants was used for determination of DNAby the method of Burton75.
Binding to Calf Thymus DNA Calf thymus DNA(0.25 mg/ml) was incubated with 100 ptM anthracycline at 37°C in 2 ml HBSS. The incubation mixture was subsequently extracted with water-saturated phenol -chloroform (1 : 1). Finally, the DNAwas isolated and the drug bound to it was determined as described above.
Enzymatically Stimulated DNA-binding Binding of anthracyclines to nuclear DNAin the presence of an NADPH-generatingsystem was SEPT. measured in a manner analogous to that of previous studies8>9). Rat hepatic nuclei (2 mgprotein/ml) were incubated with 100 [*m anthracyclines, 1 mg/ml NADPH,2 mg/ml G6P and 5 u/ml G6PDHat 37°C in 2 ml of 150 him KC1, 50 mMTris-HCl (pH 7.4) under an air atmosphere. The nuclei were then centrifuged and washed with 150 mMKC1, 50 mMTris-HCl (pH 7.4). The nuclei were treated with SDS, EDTAand proteinase K. The DNAwas isolated and the drug bound to it was determined as described above.
Results Cytotoxicity MX2and R20X2inhibited the growth of P388 cells in a concentration dependent manner after 1 hour of exposure. The IC50 values for MX2and R20X2 were 103 and 6.2 nM, respectively.
Intracellular
and Intranuclear Concentrations After 1 hour of incubation of P388 cells with 1 [jlm. anthracyclines, the distributions of the drugs were determined. The amounts of MX2and R20X2 incorporated into the cell fraction were 0.159 and 0.156 nmol/106 cells, respectively, and 36.6% of MX2and 31.9% of R20X2 were located in the nuclear fraction (Table 1) . DNA-binding in P388 Cells P388 cells were exposed to 100^m MX2or R20X2, and the DNAof the cells was then isolated. The drug bound to the DNAwas determined by measuring the fluorescence of the hydrolysate of the DNA.The time course of DNA-binding is shown in Table 2 . A zero-time value was obtained by immediate (less than 10 seconds) cooling and centrifugation after mixing the cells and the drugs. The binding of R20X2 increased with time and reached 64 pmol/mg DNAafter 2 hours of exposure. The amount of MX2(27 pmol/mg DNA)bound to the DNAafter 2 hours of exposure was less than that of R20X2 and remained at the 0-time level (Table 2 ).
DNA-intercalation
Binding to Calf Thymus DNA Calf thymus DNAwas incubated with 100^m MX2or R20X2, and the drug bound to the DNA was determined. The binding of R20X2 increased with time and reached 189 pmol/mg DNAafter The drugs (100 ixm) were incubated with a) P388 cells, b) calf thymus DNAor c) rat hepatic nuclei. The amounts at which they bound to the DNAwere determined. Each value represents the mean±SDof 3 determinations. a With the NADPH-generating system. b Without the NADPH-generatingsystem.
2 hours of exposure. The binding of MX2increased slowly, reaching a value of 3.4 pmol/mg DNA which was 56 times less than that of R20X2 (Table 2) .
Enzymatically Stimulated DNA-binding Rat hepatic nuclei were incubated with 100 im MX2or R20X2in the presence of the NADPHgenerating system, and the drug bound to the DNAwas determined. The binding of the drugs increased with time, the amount of MX2bound reached 96 pmol/mg DNA,exceeding that of R20X2 (67 pmol/mg DNA)after 2 hours of exposure. This is in a striking contrast to the data obtained with P388 cells or calf thymus DNA,Without the NADPH-generating system, the amount of MX2bound to the DNAremained at the 0-time level, while that of R20X2 increased (Table 2) .
Discussion
MX2was 16 times less cytotoxic than R20X2, according to the IC50 for the growth of P388 cells. WhenP388 cells were incubated with MX2or R20X2, both the intracellular concentration and distribution of MX2were similar to those of R20X2. Analysis of intracellular drugs by HPLCshowed neither MX2nor R20X2to be metabolized in the cells and each remained unchanged (unpublished data). Thus, the difference between the drugs in cytotoxicity against P388 cells arises not from their concentrations near target molecules but from their intrinsic activities for reacting with the molecules.
Anthracyclines have been shown to intercalate with DNA10), and bind irreversibly to DNA4), thereby altering the DNAtemplate and inhibiting nucleic acid synthesis. When the DNA-intercalations of MX2and R20X2were measured fluorometrically, no significant difference between the drugs in binding parameters could be found.
On irreversible binding, distinct differences were noted between the drugs. After incubating P388 cells with MX2or R20X2, the amount of drug bound to the DNAof the cells was measured by the method ofWallace and Johnson95 for demonstrating the binding of doxorubicin to hepatic nuclear DNA. The amount of MX2bound to DNAin P388 cells was half that of R20X2 after 1 hour of incubation. The amount of R20X2bound to DNAdepended on incubation time, while this was not the case for the amount of MX2.The higher cytotoxicity of R20X2thus appears due to its higher DNA-binding activity.
This possibility is supported by the fact that morpholino anthracyclines possessing higher/lower cytotoxicity became bound to DNAto a greater/lesser extent than the parent drugs by 1 hour of incubation with P388 cells (Table 3) . The reason why a significant amount of MX2bound to DNAat 0-time is uncertain, though possibly this may have occurred during the isolation of DNA.
Sinha et a/.8) consider that free radical intermediates are formed from doxorubicin during enzymatic activation, and then bind to DNA. Such a mechanism of DNA-binding is supported by the reported detection of electron spin resonance signals of free radicals in an incubation mixture of doxorubicin, hepatic nuclei and NADPH,and detection of the drug bound to DNAfrom this incubation mixture. When MX2was incubated with hepatic nuclei in the presence of NADPH, the amount of MX2bound to the DNAincreased with time, and exceeded that of R20X2. This is inconsistent with the results obtained by the incubation of these drugs with P388 cells. MX2bound to the DNAof P388 cells less than did R20X2. It would thus appear that non enzymatic mechanisms are very significantly operative in the DNA-binding of MX2and R20X2 in P388 cells. SEPT. 1989 DXR, doxorubicin; M13DH-DM, S'-deaminoO'-morpholino-^-dihydrodaunomycin ; 13DH-DM, 13-dihydrodaunomycin ; M13DH-DXR, 3r-deamino-3'-morpholino-13-dihydrodoxorubicin ; 13DH-DXR, 13-dihydrodoxorubicin. sensitivity of MX2and R20X2 to enzymatic Regarding the first possibility, Capranico et a/.n) suggest that mechanisms other than free radical formation are responsible for damage to DNAby doxorubicin, since depletion of glutathione failed to increase the cytotoxicity of doxorubicin in Chinese hamster ovary cells, V-79 cells, human carcinoma cells and P388 cells. In contrast, Sinha et al.w found MCF-7humanbreast cancer cells produce free radicals on exposure to doxorubicin and someradical scavengers to be capable of lessening the cytotoxicity of doxorubicin toward MCF-7cells. Enzymeactivity responsible for the formation of anthracycline radicals maypossibly vary according to cell type and this would account for differences in binding.
As for the second possibility, the amount of doxorubicin (1,030 pmol/mg DNA)bound to DNA was more than 10 times that of MX2(96 pmol/mg DNA)when they were incubated with hepatic nuclei and the NADPHgenerating system for 2 hours. Thus possibly MX2and R20X2 have little sensitivity toward enzymatic reduction or radical intermediates generated from them may have little activity for binding to DNA. The anthracycline reducing activity of tumor cells and sensitivity of anthracyclines to enzymatic reduction may act in concert to influence the PNA-binding and cytotoxicity of anthracyclines. Thus cell lines of clinical importance should be used for future study on DNAbinding.
